Jacobsen Capital Management Abbott Laboratories Transaction History
Jacobsen Capital Management
- $270 Million
- Q2 2025
A detailed history of Jacobsen Capital Management transactions in Abbott Laboratories stock. As of the latest transaction made, Jacobsen Capital Management holds 3,514 shares of ABT stock, worth $451,724. This represents 0.18% of its overall portfolio holdings.
Number of Shares
3,514
Previous 3,069
14.5%
Holding current value
$451,724
Previous $407,000
17.2%
% of portfolio
0.18%
Previous 0.18%
Shares
7 transactions
Others Institutions Holding ABT
# of Institutions
3,575Shares Held
1.38BCall Options Held
9.72MPut Options Held
8.83M-
Vanguard Group Inc Valley Forge, PA170MShares$21.8 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY131MShares$16.9 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.7MShares$9.98 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA66.8MShares$8.59 Billion1.82% of portfolio
-
Capital Research Global Investors Los Angeles, CA50.7MShares$6.52 Billion1.53% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $225B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...